Patents expiring in 2038

US 10113145

Paenibacillus sp. strain, cultivation method and use of the same

BRIGHT DAIRY & FOOD CO., LTD. · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10111957

Inhalation compositions comprising glucose anhydrous

ARVEN ILAC SANAYI VE TICARET A.S. · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10111953

Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)

REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10112900

Modified amino acids

Sutro Biopharma, Inc. · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10112917

Therapeutic compounds

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10111937

Method of reducing accumulation of intracellular tingible body macrophages

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10111926

Selectively targeted antimicrobial peptides and the use thereof

The Regents of the University of California · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10111925

Formulations comprising plant extracts

MONTERO GIDA SANAYI VE TICARET A.S. · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10111927

Pseudomonas exotoxin A with less immunogenic B cell epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3394627

RATIOMETRISCH GEPULSTE CEST-BILDGEBUNG

BRACCO IMAGING SPA [IT] · Granted Wed Oct 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

HK 1249412

PHARMACEUTICAL PRODUCT COMPRISING MITE ALLERGEN EXTRACT(S) AND A METHOD FOR THE MANUFACTURE THEREOF

ALK ABELLO AS · Granted Fri Nov 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Thu Oct 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117882

Anti-inflammatory properties of marine lipid compositions

AKER BIOMARINE ANTARCTIC AS · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118938

Arsenoplatin anti-cancer agents

Northwestern University · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117848

Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof

Milestone Pharmaceuticals Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117878

Ligands for nematode nuclear receptors and uses thereof

The Board of Regents of the University of Texas System · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117871

3-hydroxypyrimidine-2,4-dione-5-carboxamides as potent inhibitors of HIV

Regents of the University of Minnesota · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117899

Delivery methods and compositions for nuclease-mediated genome engineering in hematopoietic stem cells

Sangamo Therapeutics, Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117912

Drug delivery method

Regents of the University of Minnesota · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117928

Annexin II compositions

Regents of the University of Minnesota · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117936

Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

TONIX PHARMA LIMITED · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117937

Highly branched alpha-D-glucans

Phytoption LLC · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117915

Modulation of yeast-based immunotherapy products and responses

The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117942

Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117941

Lipids and compositions for the delivery of therapeutics

ARBUTUS BIOPHARMA CORPORATION · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117944

Targeted therapeutics

Madrigal Pharmaceuticals, Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117947

Virus-like particle conjugates for diagnosis and treatment of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118881

Hydroxyl compounds and compositions for cholesterol management and related uses

Esperion Therapeutics, Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118923

Compositions and methods for inhibiting kinases

Inhibikase Therapeutics, Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118902

Small molecule agonists of neurotensin receptor 1

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118932

Solid state forms of spiro-oxindole compounds

Xenon Pharmaceuticals Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118942

Toll-like receptor 2 ligands and methods of making and using thereof

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10119143

Compositions and methods for inhibiting expression of the ALAS1 gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10119172

Methods and reagents for detecting ebola virus

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118961

Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV

CytomX Therapeutics, Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10119140

Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscular dystrophy

BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118947

Modulation of structured polypeptide specificity

BicycleRD Limited · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117831

Soft chew pharmaceutical formulations

First Time US Generics LLC · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117852

Glucocorticoid receptor modulators to treat pancreatic cancer

Corcept Therapeutics Incorporated · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117907

Glycosylated PACAP/VIP analogues with enhanced CNS penetration for treatment of neurodegenerative diseases

Arizona Board of Regents on Behalf of the University of Arizona, a body corporate · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117938

Pharmaceutical formulation

Semnur Pharmaceuticals, Inc. · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10117945

mTORC1 inhibitors

The Regents of the University of California · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118904

Triazoles for the treatment of Demyelinating Diseases

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10118948

Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10123518

Genetically modified non-human animals and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10123984

Neprilysin inhibitors

Theravance Biopharma R&D IP, LLC · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10125128

GLS1 inhibitors for treating disease

The Board of Regents of the University of Texas System · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10125131

Selective HDAC3 inhibitors

Regenacy Pharmaceuticals, Inc. · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10125167

Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)